The Alpha Emitter Market, valued at USD 536.5 million in 2023, is projected to surpass USD 1,323.0 million by 2030, growing at an impressive CAGR of 13.8% during the forecast period of 2024–2030. The rising prevalence of cancer, increasing adoption of targeted radiotherapy, and technological advancements in alpha emitter production are key factors driving the market's rapid...